Loading clinical trials...

Decision Support Intervention of Minor Cancer Patients and Their Parents | Clinical Trials | Clareo Health

RECRUITINGNA

Decision Support Intervention of Minor Cancer Patients and Their Parents

Effectiveness Evaluation on the Decision Preferences and Decision Support Intervention of Minor Cancer Patients and Their Parents

NCT06651242•Kaohsiung Medical University Chung-Ho Memorial Hospital

View on ClinicalTrials.gov

Summary

The purpose of this stuidy are: (1) to explore the information needs of parents having children with cancer when making treatment decisions; (2) to develop a Taiwan version of the Control Preferences Scale for decision support aids; (3) to implement and evaluate the effectiveness of involving minor cancer patients and their parents in treatment decision-making.

Eligibility

Age

7 - 20 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Age over 20 years.
•2. Child under 20 years old, diagnosed with cancer by a doctor.
•3. their child know her/his cancer diagnosis.
•4. Agree to have the child participate in family meeting and have ability to communicate in Mandarin or Taiwanese.
•1. Aged between 7 and 20 years, diagnosed with pediatrtic cancer.
•2. Aware of their cancer diagnosis.
•3. Able to express their thoughts to the researcher in Mandarin or Taiwanese.
•4. Both the minor and their legal guardian consent to participate in the study.

Exclusion Criteria

•1. Diagnosed with depression, and/or anxiety, and/or other mental disorders.
•2. Legal guardian is unwilling to inform the minor of their diagnosis.
•3. Minor is unwilling to share their thoughts with their parents.

Locations (1)

Kaohsiung Medical University

Kaohsiung City, Taiwan

Key Dates

Start Date

October 26, 2022

Primary Completion Date

July 31, 2027

Completion Date

July 31, 2027

Last Updated

August 28, 2025

Enrollment

ESTIMATED participants

Conditions

Pediatric CancerAdolescent HealthDecision AidsParents of Children With CancerDecision Making ,Shared

Interventions

Decision-making information aids

OTHER

Routine care

OTHER

Contacts

Li-Min Wu, PhD

CONTACT

(886)73121101 painting@kmu.edu.tw

Lurbinectedin in FET-Fused Tumors

NCT05918640

Ewing SarcomaDesmoplastic Small Round Cell Tumor+2 more

View study

RECRUITING

Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )

NCT07368582

Pediatric CancerPediatric Cancer Patients+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 28, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Decision Support Intervention of Minor Cancer Patients and Their Parents

Inclusion Criteria

Exclusion Criteria

Lurbinectedin in FET-Fused Tumors

Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )

European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors

Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention